230 related articles for article (PubMed ID: 23397238)
1. MicroRNA-153 is tumor suppressive in glioblastoma stem cells.
Zhao S; Deng Y; Liu Y; Chen X; Yang G; Mu Y; Zhang D; Kang J; Wu Z
Mol Biol Rep; 2013 Apr; 40(4):2789-98. PubMed ID: 23397238
[TBL] [Abstract][Full Text] [Related]
2. Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57.
Zhu X; Prasad S; Gaedicke S; Hettich M; Firat E; Niedermann G
Oncotarget; 2015 Jan; 6(1):171-84. PubMed ID: 25426558
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-203 As a Stemness Inhibitor of Glioblastoma Stem Cells.
Deng Y; Zhu G; Luo H; Zhao S
Mol Cells; 2016 Aug; 39(8):619-24. PubMed ID: 27484906
[TBL] [Abstract][Full Text] [Related]
4. Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens.
Kelly JJ; Stechishin O; Chojnacki A; Lun X; Sun B; Senger DL; Forsyth P; Auer RN; Dunn JF; Cairncross JG; Parney IF; Weiss S
Stem Cells; 2009 Aug; 27(8):1722-33. PubMed ID: 19544433
[TBL] [Abstract][Full Text] [Related]
5. Down-expression of miR-154 suppresses tumourigenesis in CD133(+) glioblastoma stem cells.
Yang L; Yan Z; Wang Y; Ma W; Li C
Cell Biochem Funct; 2016 Aug; 34(6):404-13. PubMed ID: 27338789
[TBL] [Abstract][Full Text] [Related]
6. Girdin maintains the stemness of glioblastoma stem cells.
Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T
Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337
[TBL] [Abstract][Full Text] [Related]
7. CD133 is essential for glioblastoma stem cell maintenance.
Brescia P; Ortensi B; Fornasari L; Levi D; Broggi G; Pelicci G
Stem Cells; 2013 May; 31(5):857-69. PubMed ID: 23307586
[TBL] [Abstract][Full Text] [Related]
8. Novel anti-apoptotic microRNAs 582-5p and 363 promote human glioblastoma stem cell survival via direct inhibition of caspase 3, caspase 9, and Bim.
Floyd DH; Zhang Y; Dey BK; Kefas B; Breit H; Marks K; Dutta A; Herold-Mende C; Synowitz M; Glass R; Abounader R; Purow BW
PLoS One; 2014; 9(5):e96239. PubMed ID: 24805821
[TBL] [Abstract][Full Text] [Related]
9. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.
Gao X; Jin W
Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866
[TBL] [Abstract][Full Text] [Related]
10. Functional differences of miR-125b on the invasion of primary glioblastoma CD133-negative cells and CD133-positive cells.
Shi L; Wan Y; Sun G; Gu X; Qian C; Yan W; Zhang S; Pan T; Wang Z; You Y
Neuromolecular Med; 2012 Dec; 14(4):303-16. PubMed ID: 22711523
[TBL] [Abstract][Full Text] [Related]
11. Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro.
McCord AM; Jamal M; Shankavaram UT; Lang FF; Camphausen K; Tofilon PJ
Mol Cancer Res; 2009 Apr; 7(4):489-97. PubMed ID: 19372578
[TBL] [Abstract][Full Text] [Related]
12. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.
Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C
Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687
[TBL] [Abstract][Full Text] [Related]
14. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.
Liu Q; Nguyen DH; Dong Q; Shitaku P; Chung K; Liu OY; Tso JL; Liu JY; Konkankit V; Cloughesy TF; Mischel PS; Lane TF; Liau LM; Nelson SF; Tso CL
J Neurooncol; 2009 Aug; 94(1):1-19. PubMed ID: 19468690
[TBL] [Abstract][Full Text] [Related]
15. CD133 as a marker for regulation and potential for targeted therapies in glioblastoma multiforme.
Choy W; Nagasawa DT; Trang A; Thill K; Spasic M; Yang I
Neurosurg Clin N Am; 2012 Jul; 23(3):391-405. PubMed ID: 22748652
[TBL] [Abstract][Full Text] [Related]
16. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.
Silber J; Lim DA; Petritsch C; Persson AI; Maunakea AK; Yu M; Vandenberg SR; Ginzinger DG; James CD; Costello JF; Bergers G; Weiss WA; Alvarez-Buylla A; Hodgson JG
BMC Med; 2008 Jun; 6():14. PubMed ID: 18577219
[TBL] [Abstract][Full Text] [Related]
17. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
[TBL] [Abstract][Full Text] [Related]
18. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
19. MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells.
Gal H; Pandi G; Kanner AA; Ram Z; Lithwick-Yanai G; Amariglio N; Rechavi G; Givol D
Biochem Biophys Res Commun; 2008 Nov; 376(1):86-90. PubMed ID: 18765229
[TBL] [Abstract][Full Text] [Related]
20. Brain tumor stem cells from an adenoid glioblastoma multiforme.
Oka N; Soeda A; Noda S; Iwama T
Neurol Med Chir (Tokyo); 2009 Apr; 49(4):146-50; discussion 150-1. PubMed ID: 19398857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
